Parlodel SRO in Parkinson’s Disease: A Double-Blind Randomized Comparison of Parlodel Standard and Parlodel SRO
Autor: | J.P.W.F. Lakke, J.A. Haas, J.J. Van der Sande, E.N.H. Jansen, A. Staal-Schreinemachers |
---|---|
Rok vydání: | 1992 |
Předmět: |
Male
Pediatrics medicine.medical_specialty Levodopa Parkinson's disease medicine.medical_treatment Administration Oral Galenic formulation Double blind Degenerative disease Double-Blind Method medicine Humans Bromocriptine Aged Neurologic Examination Chemotherapy business.industry Levodopa therapy Parkinson Disease Middle Aged medicine.disease Surgery Neurology Delayed-Action Preparations Drug Therapy Combination Female Neurology (clinical) business medicine.drug |
Zdroj: | European Neurology. 32:318-320 |
ISSN: | 1421-9913 0014-3022 |
DOI: | 10.1159/000116852 |
Popis: | In this study, we compared in an intent-to-treat analysis the tolerance and efficacy of Parlodel SRO with its standard galenic formulation in 34 patients with Parkinson's disease who received optimal levodopa therapy. The results suggest that Parlodel SRO was equally efficacious as Parlodel standard, but Parlodel SRO is better tolerated. |
Databáze: | OpenAIRE |
Externí odkaz: |